Targeted molecules in small cell lung cancer
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 31, 106-111
- https://doi.org/10.1053/j.seminoncol.2003.12.021
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Molecular and cellular biology of small cell lung cancerSeminars in Oncology, 2003
- Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive MalignanciesJournal of Clinical Oncology, 2002
- Overview of rationale and clinical trials with signal transduction inhibitors in lung cancerSeminars in Oncology, 2002
- Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571Oncogene, 2000
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- Molecular pathogenesis of lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Selective Sp1 Binding Is Critical for Maximal Activity of the Human c-kit PromoterBlood, 1998
- Molecular abnormalities in lung cancer.Journal of Clinical Oncology, 1998
- Steel Factor and c-kit Protooncogene: Genetic Lessons in Signal TransductionCritical Reviews™ in Oncogenesis, 1994
- NCAM: a surface marker for human small cell lung cancer cellsFEBS Letters, 1990